BioLife Solutions, Inc.
BLFS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,029,572 | $1,076,557 | $1,211,005 |
| - Cash | $29,481 | $31,902 | $66,945 | $95,386 |
| + Debt | $11,007 | $23,815 | $26,948 | $30,174 |
| Enterprise Value | – | $1,021,485 | $1,036,560 | $1,145,793 |
| Revenue | $28,067 | $25,421 | $23,941 | -$3,424 |
| % Growth | 10.4% | 6.2% | 799.2% | – |
| Gross Profit | $18,779 | $16,433 | $15,786 | $8,271 |
| % Margin | 66.9% | 64.6% | 65.9% | -241.6% |
| EBITDA | $2,546 | -$14,330 | $166 | $6,747 |
| % Margin | 9.1% | -56.4% | 0.7% | -197.1% |
| Net Income | $621 | -$15,838 | -$448 | $12,459 |
| % Margin | 2.2% | -62.3% | -1.9% | -363.9% |
| EPS Diluted | 0.01 | -0.33 | -0.01 | 0.26 |
| % Growth | 103% | -3,373.7% | -103.7% | – |
| Operating Cash Flow | $6,104 | $7,368 | $1,727 | $1,645 |
| Capital Expenditures | -$3,302 | -$1,743 | -$175 | -$1,062 |
| Free Cash Flow | $2,802 | $5,625 | $1,552 | $583 |